// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























7277 Abstracts

Impact for Discontinuation of Dual Antiplatelet Therapy for Unexpected Reason Within 3 Months After 2nd Drug Eluting Stent Implantation

Yohsuke Honda - Angioplasty Summit-TCTAP , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Nine-Month Outcomes Following Primary PCI with Bioresorbable Vascular Scaffold Implantation in Patients with ST-Segment Myocardial Infarction: Results from the Multicentre 'Registro ABSORB Italiano' (RAI Registry)

Alfonso Ielasi - Angioplasty Summit-TCTAP , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Incidence of Sub-Acute Stent Thrombosis in Patients with ST-Segment Elevation Myocardial Infarction: Comparison with Elective Patients and Impact of Two-Stent Procedure

Hidewo Amano - Angioplasty Summit-TCTAP , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Worst Fatal Cath Lab Case Scenario of 58 Years Old Male with Acute Inferoposterior Wall Myocardial Infarction Who Underwent Right Radial Primary PCI Followed by Subacute Scaffold Thrombosis After 36 Hours with Totally Occluded Abdominal Aorta

Mohan Mani - Angioplasty Summit-TCTAP , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Atorvastatin

Successful Management of LM STEMI Complicated with Cardiogenic Shock and Multiple Organ Failure

Tung-Lin Tsui - Angioplasty Summit-TCTAP , 2015

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Coronary Pseudoaneurysm After Transluminal Coronary Rotational Atherectomy

Wei Wu - Angioplasty Summit-TCTAP , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Protamine Sulfate

Longitudinal Sent Deformation. Any DES?

Basem Elsaid Enany - Angioplasty Summit-TCTAP , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Retrograde Approach in RCA Full Metal Jacket with Low Ejection Fraction

Feng Yu Kuo - Angioplasty Summit-TCTAP , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Inferior Vena Caval Filter in the Treatment of Protein S Deficient Chronic Thrombo - Embolic Pulmonary Hypertension with Deep Vein Thrombosis

Afzalur Rahman - Angioplasty Summit-TCTAP , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fibrinogen (IV)

Intracoronary Imaging to Guide PCI

Sohail Q. Khan - Angioplasty Summit-TCTAP , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

Prasugrel

Coronary Aneurysm and Stent Fracture Following Stenting of a Myocardial Bridge

Hao Lu - Angioplasty Summit-TCTAP , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

CARDIOVASCULAR RISK AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH GOUT: EXPERIENCE IN A MULTIHOSPITAL SPANISH GROUP

E. Calvo Aranda - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Angiotensin II

COMORBIDITY PATTERN AT THE TIME OF GOUT DIAGNOSIS: A POPULATION- AND REGISTER-BASED CASE-CONTROL STUDY FROM WESTERN SWEDEN

P. Drivelegka - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Cyclosporine eent

ANALYSIS OF INTERLEUKIN-1? INHIBITOR (CANAKINUMAB) IMPACT ON ENDOTHELIAL DYSFUNCTION

M. Eliseev - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

ILS-969

RELATIONSHIP SCD36 LEVELS AND DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS

A.A. Saldana Millan - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

POST-PROCESSING TECHNIQUES FOR ENHANCED VISUALIZATION OF PULMONARY VASCULITIS AND PULMONARY THROMBOSIS BY MULTISLICE SPIRAL COMPUTED TOMOGRAPHY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME

I. Leineman - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

RISK FACTORS FOR LENGTH OF HOSPITAL STAY AFTER TOTAL KNEE ARTHROPLASTY: A FIVE-YEAR CONSECUTIVE CASE SERIES

K. Kawakami - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

EVOLUTION AND OUTCOMES OF PREGNANCIES IN PATIENTS WITH SYSTEMIC INFLAMMATORY RHEUMATIC DISEASES

E. Vicens Bernabeu - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Salicylic acid

PREVALENCE OF PREVIOUS PFAPA SYNDROME IN BEHCE-S DISEASE

P. Ene - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Venous thrombosis

N/A

CHILDHOOD-ONSET EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: A RARE CHILDHOOD VASCULITIS MIMICKING ANTHRAX AND EOSINOPHILIC LEUKEMIA

S. Sahin - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Methylprednisolone

Copyright © 2026. QuantiNova All rights reserved